Clinical Trials
13 trialsNCT05694819 2026-04-08
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
National Cancer Center Hospital East
Phase 2 Completed
NCT06365788 2026-04-01
ABBICAR
Universitaire Ziekenhuizen KU Leuven
Phase 2 Recruiting
NCT04090528 2025-12-05
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
University of Wisconsin, Madison
Phase 2 Active not recruiting
NCT01793168 2025-05-29
CoRDS
Sanford Health
Recruiting
NCT04926181 2025-05-15
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
NCT05062174 2022-12-15
Breast Cancer BRCA1 Carriers: a Pilot Study
Indiana University
Withdrawn
NCT05157373 2021-12-15
AREC
University of Nicosia
Unknown
NCT03050866 2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2 Unknown
NCT00878436 2018-02-07
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
NYU Langone Health
Phase 1/2 Completed
NCT02348281 2018-01-23
Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients
Fudan University
Phase 2 Terminated
NCT02910050 2017-12-22
BETTER
Sun Yat-sen University
Phase 2 Unknown
NCT00365599 2014-11-21
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00918385 2014-10-29
ARS
Duke University
Phase 2 Terminated